Actively Recruiting

Phase Not Applicable
Age: 20Years - 89Years
All Genders
Healthy Volunteers
NCT07145970

Standardization of Spatial Neglect Assessment Tests

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-10

210

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention. This research focuses on defining norms for tests to assess spatial neglect. The norms correspond to the results obtained in a population free of any disorder that could have an impact on test performance. These results can vary in a normal, non-pathological way, with certain parameters such as age, sex, laterality or level of education. Defining these norms in healthy volunteers is therefore essential for interpreting results in patients suspected of spatial neglect, and in particular for defining pathological thresholds above which the diagnosis of spatial neglect can be retained. To answer the research question, we plan to include 210 people with no central neurological disease (stroke, epilepsy and multiple sclerosis in particular), in a single-center study in the neurovascular department of the Raymond-Poincaré hospital (Garches). The 210 subjects will be divided into 10-year age groups, from 20 to 89 years, with the recruitment of 30 participants per age group (15 men and 15 women): 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, 80-89 years.

CONDITIONS

Official Title

Standardization of Spatial Neglect Assessment Tests

Who Can Participate

Age: 20Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
  • Aged between 20 and 89 years
  • Affiliated with a health insurance scheme
  • French-speaking
  • Has freely and knowingly expressed their non-opposition
Not Eligible

You will not qualify if you...

  • Known history of central neurological disease such as stroke, transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy
  • Medical history suggesting past central nervous system problems like sensorimotor deficits, speech or vision issues, or hallucinations
  • Significant vision impairment in near vision despite correction or blindness in one eye
  • Abnormal neurological exam including NIH Stroke Scale score above 0 or pyramidal reflex syndrome
  • Use of alcohol or drugs within 24 hours before assessment
  • Presence of cognitive or psychiatric disorders as assessed by the examiner
  • Language barrier or aphasia
  • Participant under legal protection such as guardianship or curatorship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Raymond Poincarré

Garche, France, 92380

Actively Recruiting

Loading map...

Research Team

J

Jean-Baptiste BRUNET de COURSSOU, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here